Does ESKETAMINE Cause Product packaging quantity issue? 12 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product packaging quantity issue have been filed in association with ESKETAMINE (Spravato). This represents 0.1% of all adverse event reports for ESKETAMINE.
12
Reports of Product packaging quantity issue with ESKETAMINE
0.1%
of all ESKETAMINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From ESKETAMINE?
Of the 12 reports, and 1 (8.3%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESKETAMINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ESKETAMINE Cause?
Dissociation (3,103)
Sedation (2,244)
Suicidal ideation (1,254)
Drug ineffective (1,005)
Nausea (807)
Depression (800)
Anxiety (659)
Hospitalisation (657)
Product dose omission issue (635)
Hypertension (605)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which ESKETAMINE Alternatives Have Lower Product packaging quantity issue Risk?
ESKETAMINE vs ESLICARBAZEPINE
ESKETAMINE vs ESMOLOL
ESKETAMINE vs ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\NAPROXEN